Department of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburggrid.8761.8, Gothenburg, Sweden.
Center for Antibiotic Resistance Research (CARe), University of Gothenburggrid.8761.8, Gothenburg, Sweden.
Microbiol Spectr. 2022 Aug 31;10(4):e0218121. doi: 10.1128/spectrum.02181-21. Epub 2022 Jun 28.
The approach of sequencing or genotyping to characterize the pathogenic potential of staphylococci from orthopedic device-related infection (ODRI) has been applied in recent studies. These studies described the genomic carriage of virulence in clinical strains and compared it with those in commensal strains. Only a few studies have directly correlated genomic profiles to patient outcome and phenotypic virulence properties in periprosthetic joint infections (PJIs). We investigated the association between genomic variations and virulence-associated phenotypes (biofilm-forming ability and antimicrobial resistance) in 111 staphylococcal strains isolated from patients with PJI and the infection outcome (resolved/unresolved). The presence of a strong biofilm phenotype in Staphylococcus aureus and an antibiotic-resistant phenotype in Staphylococcus epidermidis were both associated with treatment failure of PJI. In S. epidermidis, multidrug resistance (MDR) and resistance to rifampicin were associated with unresolved infection. Sequence type 45 (ST45) and ST2 were particularly enriched in S. aureus and S. epidermidis, respectively. S. epidermidis ST2 caused the majority of relapses and was associated with MDR and strong biofilm production, whereas ST215 correlated with MDR and non/weak biofilm production. S. aureus II correlated with resolved infection, while S. epidermidis I was associated with strong biofilm production and III with non/weak production. Collectively, our results highlight the importance of careful genomic and phenotypic characterization to anticipate the probability of the strain causing treatment failure in PJI. Due to the high rate of resistant S. epidermidis strains identified, this study provides evidence that the current recommended treatment of rifampicin and a fluoroquinolone should not be administered without knowledge of the resistance pattern. This study addresses the presence and frequency of particular genetic variants and virulence factors found in staphylococcal bacteria causing periprosthetic joint infection (PJI) of the hip and knee to ascertain their clinical relevance as predictors of treatment failure. We characterized the genetic virulence traits of a large collection of clinical staphylococci isolated from patients with PJI and evaluated their association with the patient's infection outcome. The results showed that S. aureus strains that produced strong biofilms and S. epidermidis strains with resistance to several antibiotics associated significantly with unresolved infection. Some particular genetic variants associated with biofilm formation and multidrug resistance. These traits should be considered important risk factors for the diagnosis and treatment guidance in PJI.
最近的研究中,已经采用测序或基因分型方法来描述与骨科器械相关感染(ODRI)的葡萄球菌的致病潜力。这些研究描述了临床菌株中携带的毒力基因,并将其与共生菌株进行了比较。只有少数研究直接将基因组图谱与假体周围关节感染(PJI)患者的临床结果和表型毒力特性相关联。我们调查了 111 株从 PJI 患者中分离的葡萄球菌菌株的基因组变异与毒力相关表型(生物膜形成能力和抗微生物药物耐药性)之间的关系,以及感染结果(痊愈/未痊愈)。金黄色葡萄球菌中强生物膜表型和表皮葡萄球菌中抗生素耐药表型均与 PJI 治疗失败相关。表皮葡萄球菌中,多重耐药(MDR)和对利福平的耐药性与未痊愈感染相关。ST45 和 ST2 分别在金黄色葡萄球菌和表皮葡萄球菌中特别丰富。表皮葡萄球菌 ST2 引起了大多数复发,与 MDR 和强生物膜形成有关,而 ST215 与 MDR 和非/弱生物膜形成有关。金黄色葡萄球菌 II 与痊愈感染相关,而表皮葡萄球菌 I 与强生物膜形成相关,III 与非/弱生物膜形成相关。总的来说,我们的结果强调了仔细的基因组和表型特征分析对于预测菌株在 PJI 中引起治疗失败的可能性的重要性。由于鉴定出的耐药表皮葡萄球菌菌株率很高,本研究表明,在不了解耐药模式的情况下,不应使用推荐的利福平加氟喹诺酮治疗方法。本研究旨在确定导致髋关节和膝关节假体周围关节感染(PJI)的葡萄球菌中特定遗传变异体和毒力因子的存在和频率,以确定它们作为治疗失败预测因子的临床相关性。我们对从 PJI 患者中分离的大量临床葡萄球菌进行了遗传毒力特征分析,并评估了它们与患者感染结果的关联。结果表明,产生强生物膜的金黄色葡萄球菌菌株和对多种抗生素耐药的表皮葡萄球菌菌株与未痊愈感染显著相关。一些与生物膜形成和多药耐药相关的特定遗传变异体。这些特征应被视为 PJI 诊断和治疗指导的重要危险因素。